GlassScriptPhysician profile
Jan Jay Rigney
NPI 1548278112
$3,457.73
in general payments reported to CMS, 2019-2025
8 companies · $300 in 2025
The $300 reported for 2025 was more than what a typical Pediatrics (Optometrist) provider received nationally (typical 2025 total: $152).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,743 · 2020: $202 · 2021: $124 · 2022: $407 · 2023: $359 · 2024: $322 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $981.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,780.16 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $848.50 | 2022-2025 | Infuse, Multi-Focal Lens, Biotrue One Day |
| Abbvie INC. | $264.11 | 2022-2025 | Durysta |
| Allergan, INC. | $255.48 | 2019-2022 | |
| Alcon Vision LLC | $129.00 | 2019-2023 | Total30 |
| Johnson & Johnson Vision Care, INC. | $103.11 | 2019-2022 | |
| Astellas Pharma US INC | $65.03 | 2024 | Izervay |
| Abb Con-Cise Optical Group LLC | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Rigney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.